Spreadsheet: 2887641e-53c9-4107-bb93-a6d00d393541
Sheet: Sheet1

ID | [NAME] | Species | GOTERM_BP_FAT | GOTERM_CC_FAT | GOTERM_MF_FAT | KEGG_PATHWAY | OMIM_DISEASE
ADAM17 | ADAM metallopeptidase domain 17 | Homo sapiens | [NAME]~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001558~regulation of cell growth,[NAME]~response to hypoxia,GO:0001775~cell activation,GO:0001817~regulation of cytokine production,GO:0001818~negative regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0002237~response to molecule of bacterial origin,GO:0002250~adaptive immune response,GO:0002252~immune effector process,[NAME] mediated immunity,GO:0002444~myeloid [NAME] mediated immunity,GO:0002446~neutrophil mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002467~germinal center formation,GO:0002520~immune system development,GO:0002521~[NAME] differentiation,GO:0002684~positive regulation of immune system process,GO:0002685~regulation of leukocyte migration,GO:0002687~positive regulation of leukocyte migration,GO:0002688~regulation of leukocyte chemotaxis,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0006916~anti-apoptosis,GO:0006928~cell motion,GO:0006955~immune response,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~[NAME] receptor [NAME] signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007176~regulation of epidermal growth factor receptor activity,GO:0007219~Notch signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008361~regulation of cell size,[NAME]macromolecule catabolic process,GO:0009611~response to wounding,GO:0009617~response to bacterium,GO:0009719~response to endogenous stimulus,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010469~regulation of receptor activity,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010647~positive regulation of cell communication,GO:0010819~regulation of T cell chemotaxis,GO:0010820~positive regulation of T cell chemotaxis,GO:0010941~regulation of cell death,GO:0016477~cell migration,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0019220~regulation of phosphate metabolic process,[NAME]~cell cycle process,GO:0022403~cell cycle phase,GO:0022610~biological adhesion,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030163~protein catabolic process,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030307~positive regulation of cell growth,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0031293~membrane protein intracellular domain proteolysis,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031657~regulation of cyclin-dependent protein kinase activity during G1/S,GO:0031659~positive regulation of cyclin-dependent protein kinase activity during G1/S,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032496~response to lipopolysaccharide,GO:0032535~regulation of cellular component size,GO:0032642~regulation of chemokine production,GO:0032677~regulation of interleukin-8 production,GO:0032717~negative regulation of interleukin-8 production,GO:0032722~positive regulation of chemokine production,GO:0032844~regulation of homeostatic process,GO:0033025~regulation of mast cell apoptosis,GO:0033032~regulation of myeloid cell apoptosis,GO:0033077~T cell differentiation in the thymus,GO:0033619~membrane protein proteolysis,GO:0033627~cell adhesion mediated by integrin,GO:0033674~positive regulation of kinase activity,GO:0035313~wound healing, spreading of epidermal cells,GO:0040008~regulation of growth,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042058~regulation of epidermal growth factor receptor signaling pathway,GO:0042060~wound healing,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042493~response to drug,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045321~[NAME],GO:0045737~positive regulation of cyclin-dependent protein kinase activity,GO:0045741~positive regulation of epidermal growth factor receptor activity,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045787~positive regulation of cell cycle,GO:0045793~positive regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045927~positive regulation of growth,GO:0045937~positive regulation of phosphate metabolic process,GO:0046649~[NAME],GO:0048520~positive regulation of behavior,GO:0048534~hemopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0050795~regulation of behavior,GO:0050920~regulation of chemotaxis,GO:0050921~positive regulation of chemotaxis,GO:0051088~PMA-inducible membrane protein ectodomain proteolysis,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051325~interphase,[NAME]interphase of mitotic cell cycle,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,[NAME]~proteolysis involved in cellular protein catabolic process,GO:0051674~localization of cell,GO:0051726~regulation of cell cycle,[NAME]response to lipoprotein stimulus,GO:0055099~response to high density lipoprotein stimulus,GO:0060548~negative regulation of cell death,GO:0070482~response to oxygen levels, | GO:0001726~ruffle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,[NAME]cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0015629~[NAME],GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,[NAME]~apical plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031252~cell leading edge,[NAME]~cell projection membrane,GO:0031256~leading edge membrane,GO:0032587~ruffle membrane,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045121~membrane raft,GO:0045177~apical part of cell,GO:0070161~anchoring junction, | GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,[NAME]~interleukin-6 receptor binding,GO:0005178~[NAME],GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0030165~PDZ domain binding,GO:0032403~protein complex binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides, | hsa04330:Notch signaling pathway,[NAME]:Alzheimer's disease,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,
[NAME] | adducin 3 (gamma) | Homo sapiens |  | [NAME]~nuclear chromosome,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0005694~chromosome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005938~cell cortex,GO:0009898~internal side of plasma membrane,GO:0030054~cell junction,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part, | [NAME],[NAME]~protein kinase C binding,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005516~[NAME],GO:0008092~cytoskeletal protein binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,[NAME]~protein kinase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,
APPBP2 | amyloid beta precursor protein (cytoplasmic tail) binding protein 2 | Homo sapiens | GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,[NAME]~cellular macromolecule localization, | GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~[NAME],GO:0019898~extrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part, | GO:0003774~motor activity,GO:0003777~microtubule motor activity,
C4orf46 | chromosome 4 open reading frame 4 | Homo sapiens
CYTIP | cytohesin 1 interacting protein | Homo sapiens | GO:0030155~regulation of cell adhesion, | GO:0005768~endosome,GO:0005769~early endosome,GO:0005938~cell cortex,
DCK | [NAME] | Homo sapiens | GO:0006213~pyrimidine nucleoside metabolic process,GO:0006220~pyrimidine nucleotide metabolic process,GO:0009116~nucleoside metabolic process,GO:0009120~deoxyribonucleoside metabolic process,GO:0017144~drug metabolic process,GO:0046092~deoxycytidine metabolic process,GO:0046125~pyrimidine deoxyribonucleoside metabolic process, | [NAME]~cytosol, | GO:0000166~nucleotide binding,[NAME]~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0001884~pyrimidine nucleoside binding,GO:0004137~deoxycytidine kinase activity,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0017076~purine nucleotide binding,GO:0019136~deoxynucleoside kinase activity,GO:0019205~nucleobase, nucleoside, nucleotide kinase activity,GO:0019206~nucleoside kinase activity,[NAME]~[NAME] binding,GO:0032546~deoxyribonucleoside binding,GO:0032548~pyrimidine deoxyribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding, | hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,
DPYD | dihydropyrimidine dehydrogenase | Homo sapiens | GO:0006144~purine base metabolic process,GO:0006145~purine base catabolic process,GO:0006206~[NAME] process,[NAME] pyrimidine base biosynthetic process,GO:0006208~[NAME] process,GO:0006210~[NAME] process,GO:0006212~uracil catabolic process,[NAME]pyrimidine nucleoside metabolic process,GO:0006214~thymidine catabolic process,GO:0006220~pyrimidine nucleotide metabolic process,GO:0006221~pyrimidine nucleotide biosynthetic process,GO:0006222~UMP biosynthetic process,GO:0009112~nucleobase metabolic process,GO:0009116~nucleoside metabolic process,GO:0009119~ribonucleoside metabolic process,GO:0009120~deoxyribonucleoside metabolic process,GO:0009123~nucleoside monophosphate metabolic process,GO:0009124~nucleoside monophosphate biosynthetic process,GO:0009129~pyrimidine nucleoside monophosphate metabolic process,GO:0009130~pyrimidine nucleoside monophosphate biosynthetic process,[NAME]~ribonucleoside monophosphate biosynthetic process,GO:0009161~ribonucleoside monophosphate metabolic process,GO:0009164~nucleoside catabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009173~pyrimidine ribonucleoside monophosphate metabolic process,[NAME]~pyrimidine ribonucleoside monophosphate biosynthetic process,GO:0009218~pyrimidine ribonucleotide metabolic process,GO:0009220~pyrimidine ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0019856~pyrimidine base biosynthetic process,GO:0019859~thymine metabolic process,GO:0019860~uracil metabolic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0034655~nucleobase, nucleoside, nucleotide and nucleic acid catabolic process,GO:0034656~nucleobase, nucleoside and nucleotide catabolic process,GO:0044270~nitrogen compound catabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046049~UMP metabolic process,GO:0046104~thymidine metabolic process,[NAME]nucleobase biosynthetic process,GO:0046113~nucleobase catabolic process,GO:0046121~deoxyribonucleoside catabolic process,GO:0046125~pyrimidine deoxyribonucleoside metabolic process,GO:0046127~pyrimidine deoxyribonucleoside catabolic process,GO:0046131~pyrimidine ribonucleoside metabolic process,[NAME]pyrimidine nucleoside catabolic process,GO:0046700~heterocycle catabolic process,GO:0055114~oxidation reduction, | [NAME]~cytosol, | GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004152~dihydroorotate dehydrogenase activity,GO:0004158~dihydroorotate oxidase activity,GO:0004159~dihydrouracil dehydrogenase (NAD+) activity,GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0016634~oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,GO:0017076~purine nucleotide binding,GO:0017113~dihydropyrimidine dehydrogenase (NADP+) activity,[NAME]~[NAME] binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050661~NADP or NADPH binding,GO:0050662~coenzyme binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0051540~metal cluster binding, | hsa00240:Pyrimidine metabolism,hsa00410:beta-Alanine metabolism,hsa00770:Pantothenate and CoA biosynthesis,hsa00983:Drug metabolism, | 5-fluorouracil toxicity,Dihydropyrimidine dehydrogenase deficiency,Fluorouracil toxicity, sensitivity to,Thymine-uraciluria,
EXOC5 | exocyst complex component 5 | Homo sapiens | GO:0006887~exocytosis,GO:0006892~post-Golgi vesicle-mediated transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0022406~membrane docking,GO:0032940~secretion by cell,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0048278~vesicle docking,
HEXA | hexosaminidase A (alpha polypeptide) | Homo sapiens | GO:0001501~skeletal system development,GO:0001508~regulation of action potential,GO:0001573~ganglioside metabolic process,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0006643~membrane lipid metabolic process,GO:0006664~[NAME] process,GO:0006665~sphingolipid metabolic process,GO:0006672~ceramide metabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0006689~ganglioside catabolic process,GO:0006873~cellular ion homeostasis,GO:0007033~vacuole organization,GO:0007040~lysosome organization,GO:0007272~ensheathment of neurons,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0007628~adult walking behavior,GO:0008344~adult locomotory behavior,GO:0008366~[NAME] ensheathment,GO:0010876~lipid localization,GO:0016042~lipid catabolic process,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019377~glycolipid catabolic process,GO:0019725~cellular homeostasis,[NAME]~lipid storage,GO:0019953~sexual reproduction,GO:0030149~sphingolipid catabolic process,GO:0030203~glycosaminoglycan metabolic process,GO:0030534~adult behavior,GO:0042391~regulation of membrane potential,GO:0042552~myelination,GO:0042592~homeostatic process,GO:0044242~cellular lipid catabolic process,GO:0046466~membrane lipid catabolic process,GO:0046479~glycosphingolipid catabolic process,GO:0046519~sphingoid metabolic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050884~neuromuscular process controlling posture,GO:0050885~neuromuscular process controlling balance,GO:0050890~cognition,GO:0050905~neuromuscular process,GO:0050954~sensory perception of mechanical stimulus,GO:0055082~cellular chemical homeostasis, | GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole, | [NAME]beta-N-acetylhexosaminidase activity,GO:0015929~hexosaminidase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity, | hsa00511:Other glycan degradation,[NAME]:Amino sugar and nucleotide sugar metabolism,hsa00531:Glycosaminoglycan degradation,hsa00603:Glycosphingolipid biosynthesis,hsa00604:Glycosphingolipid biosynthesis,hsa04142:Lysosome, | GM2-gangliosidosis, several forms,Hex A pseudodeficiency,Tay-Sachs disease,
HNF1B | HNF1 homeobox B | Homo sapiens | GO:0001655~urogenital system development,GO:0001701~in utero embryonic development,GO:0001822~kidney development,GO:0001824~blastocyst development,GO:0001825~blastocyst formation,GO:0001826~inner cell mass cell differentiation,GO:0002790~peptide secretion,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0003002~regionalization,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,[NAME]cell-cell signaling,GO:0007389~pattern specification process,GO:0007492~endoderm development,GO:0007548~sex differentiation,GO:0008283~cell proliferation,[NAME]~response to carbohydrate stimulus,GO:0009746~response to hexose stimulus,GO:0009749~response to glucose stimulus,[NAME] ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0009914~hormone transport,GO:0009952~anterior/posterior pattern formation,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010817~regulation of hormone levels,GO:0015833~peptide transport,GO:0030072~peptide hormone secretion,GO:0030073~insulin secretion,GO:0030902~hindbrain development,GO:0031016~pancreas development,GO:0031018~endocrine pancreas development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032940~secretion by cell,GO:0034284~response to monosaccharide stimulus,GO:0035270~endocrine system development,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046879~hormone secretion,GO:0046903~secretion,GO:0048806~genitalia development,GO:0050673~epithelial cell proliferation,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process, | GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,[NAME],[NAME]~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~[NAME],GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen, | GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity, | hsa04950:Maturity onset diabetes of the young, | Diabetes mellitus, noninsulin-dependent,[NAME], type 2, protection against,Multiple loci identified in a genome-wide association study of prostate cancer,Multiple newly identified loci associated with prostate cancer susceptibility,Prostate cancer, hereditary, 11,Prostate cancer, susceptibility to,[NAME] cell carcinoma,Renal cysts and diabetes syndrome,Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes,
[NAME] | [NAME] member 3C | Homo sapiens | GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement, | GO:0005856~cytoskeleton,[NAME]~[NAME],GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~[NAME],GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part, | GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,[NAME]~[NAME],GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,
LARS2 | leucyl-tRNA synthetase 2, mitochondrial | Homo sapiens | GO:0006399~tRNA metabolic process,GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006429~leucyl-tRNA aminoacylation,GO:0034660~ncRNA metabolic process,GO:0043038~amino acid activation,GO:0043039~tRNA aminoacylation, | [NAME]~mitochondrion,GO:0005759~mitochondrial matrix,[NAME]~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~[NAME],GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen, | GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004823~leucine-tRNA ligase activity,GO:0005524~ATP binding,[NAME]ligase activity, forming carbon-oxygen bonds,GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds,GO:0017076~purine nucleotide binding,[NAME]~[NAME],GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding, | hsa00290:[NAME], leucine and isoleucine biosynthesis,[NAME]:Aminoacyl-tRNA biosynthesis,
MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | Homo sapiens | GO:0000165~MAPKKK cascade,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0016310~phosphorylation,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0046777~protein amino acid autophosphorylation, |  | GO:0000166~nucleotide binding,[NAME]~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,[NAME]~[NAME],GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding, | hsa04010:MAPK signaling pathway,[NAME]:Neurotrophin signaling pathway,[NAME]:[NAME] signaling pathway, | Many sequence variants affecting diversity of adult human height,
NUBPL | nucleotide binding protein-like | Homo sapiens |  |  | GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,[NAME]~[NAME],GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding, |  | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis,Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia,
OXTR | oxytocin receptor | Homo sapiens | GO:0000165~MAPKKK cascade,GO:0001696~gastric acid secretion,GO:0001967~suckling behavior,GO:0001975~response to amphetamine,GO:0003012~muscle system process,GO:0003013~circulatory system process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006936~muscle contraction,GO:0006937~regulation of muscle contraction,GO:0006940~regulation of smooth muscle contraction,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,[NAME]elevation of cytosolic calcium ion concentration,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,[NAME]cell-cell signaling,GO:0007268~synaptic transmission,GO:0007320~insemination,GO:0007507~heart development,GO:0007565~female pregnancy,GO:0007567~parturition,GO:0007586~digestion,GO:0007595~lactation,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007613~memory,GO:0007618~mating,GO:0007620~copulation,GO:0007631~feeding behavior,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,[NAME]~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0010647~positive regulation of cell communication,GO:0010701~positive regulation of norepinephrine secretion,[NAME]~regulation of norepinephrine secretion,GO:0014070~response to organic cyclic substance,GO:0014073~response to tropane,GO:0014075~response to amine stimulus,GO:0019098~reproductive behavior,GO:0019226~transmission of nerve impulse,GO:0019725~cellular homeostasis,GO:0021537~telencephalon development,GO:0022600~digestive system process,GO:0022602~ovulation cycle process,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030431~sleep,GO:0030879~mammary gland development,GO:0030900~forebrain development,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,[NAME]~regulation of synaptic transmission, GABAergic,GO:0032230~positive regulation of synaptic transmission, GABAergic,GO:0032355~response to estradiol stimulus,GO:0032504~multicellular organism reproduction,GO:0032570~response to progesterone stimulus,GO:0033057~reproductive behavior in a multicellular organism,GO:0033605~positive regulation of catecholamine secretion,GO:0034059~response to anoxia,GO:0034097~response to cytokine stimulus,GO:0035176~social behavior,[NAME]~response to cocaine,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042698~ovulation cycle,GO:0042711~maternal behavior,GO:0042713~sperm ejaculation,GO:0042755~eating behavior,GO:0043279~response to alkaloid,GO:0043434~response to peptide hormone stimulus,GO:0043627~response to estrogen stimulus,GO:0043900~regulation of multi-organism process,GO:0044057~regulation of system process,GO:0044058~regulation of digestive system process,GO:0044087~regulation of cellular component biogenesis,GO:0044089~positive regulation of cellular component biogenesis,GO:0045777~positive regulation of blood pressure,GO:0045933~positive regulation of muscle contraction,GO:0045987~positive regulation of smooth muscle contraction,GO:0046717~acid secretion,GO:0046903~secretion,GO:0048511~rhythmic process,GO:0048545~response to steroid hormone stimulus,GO:0048565~gut development,GO:0048609~reproductive process in a multicellular organism,GO:0048732~gland development,GO:0048878~chemical homeostasis,GO:0050433~regulation of catecholamine secretion,GO:0050801~ion homeostasis,GO:0050803~regulation of synapse structure and activity,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050807~regulation of synapse organization,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051130~positive regulation of cellular component organization,GO:0051240~positive regulation of multicellular organismal process,GO:0051480~cytosolic calcium ion homeostasis,GO:0051705~behavioral interaction between organisms,GO:0051952~regulation of amine transport,GO:0051954~positive regulation of amine transport,GO:0051960~regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0051963~regulation of synaptogenesis,GO:0051965~positive regulation of synaptogenesis,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060137~maternal process involved in parturition,GO:0060206~estrous cycle phase,GO:0060341~regulation of cellular localization,[NAME]~regulation of penile erection,GO:0060406~positive regulation of penile erection,GO:0060746~parental behavior,GO:0070371~[NAME] and ERK2 cascade,GO:0070472~regulation of uterine smooth muscle contraction,GO:0070474~positive regulation of uterine smooth muscle contraction,GO:0070482~response to oxygen levels, | GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005902~microvillus,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0016021~integral to membrane,[NAME]~apical plasma membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0070161~anchoring junction, | GO:0001653~peptide receptor activity,[NAME]~oxytocin receptor activity,GO:0005000~vasopressin receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0017046~peptide hormone binding,GO:0042277~peptide binding,GO:0042562~hormone binding, | hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,
PDE7B | phosphodiesterase 7B | Homo sapiens | GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process, |  | [NAME] phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0008081~phosphoric diester hydrolase activity, | hsa00230:Purine metabolism,
[NAME] | R-spondin family, member 4 | Homo sapiens | GO:0007166~cell surface receptor linked signal transduction,GO:0016055~Wnt receptor signaling pathway, | GO:0005576~extracellular region, | GO:0001871~pattern binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding, |  | [NAME] congenita,
SLC25A19 | solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 | Homo sapiens | GO:0006862~nucleotide transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0030302~deoxynucleotide transport,GO:0055085~[NAME], | [NAME]~mitochondrion,GO:0005740~mitochondrial envelope,[NAME]mitochondrial inner membrane,GO:0016021~integral to membrane,GO:0019866~organelle inner membrane,GO:0031090~[NAME],GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~[NAME],GO:0031975~envelope,GO:0044429~mitochondrial part, | GO:0015215~nucleotide transmembrane transporter activity,GO:0015932~nucleobase, nucleoside, nucleotide and nucleic acid transmembrane transporter activity,GO:0030233~deoxynucleotide transmembrane transporter activity, |  | Microcephaly, Amish type,
SMNDC1 | survival motor neuron domain containing 1 | Homo sapiens | [NAME]~spliceosome assembly,GO:0000375~[NAME] splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,[NAME]~apoptosis,GO:0006917~induction of apoptosis,GO:0008219~cell death,GO:0008380~[NAME] splicing,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016071~mRNA metabolic process,GO:0016265~death,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043933~macromolecular complex subunit organization,GO:0065003~macromolecular complex assembly, | GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0015030~Cajal body,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,[NAME]~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~[NAME],GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen, | GO:0003723~[NAME] binding,GO:0031202~RNA splicing factor activity, transesterification mechanism, | hsa03040:Spliceosome,
TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | Homo sapiens | GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0002791~regulation of peptide secretion,GO:0002793~positive regulation of peptide secretion,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006916~anti-apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007166~cell surface receptor linked signal transduction,[NAME],GO:0007442~hindgut morphogenesis,GO:0007548~sex differentiation,GO:0008283~cell proliferation,[NAME] ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010560~positive regulation of glycoprotein biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010908~regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010941~regulation of cell death,GO:0016055~Wnt receptor signaling pathway,GO:0019827~stem cell maintenance,[NAME]~neural tube development,[NAME]~cell cycle process,GO:0030538~embryonic genitalia morphogenesis,GO:0031016~pancreas development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032024~positive regulation of insulin secretion,GO:0032350~regulation of hormone metabolic process,GO:0032583~regulation of gene-specific transcription,GO:0033500~carbohydrate homeostasis,[NAME]~somatic stem cell maintenance,GO:0035112~genitalia morphogenesis,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0042692~muscle cell differentiation,[NAME]~regulation of sulfur metabolic process,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043193~positive regulation of gene-specific transcription,GO:0045165~cell fate commitment,GO:0045444~fat cell differentiation,GO:0045445~myoblast differentiation,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046883~regulation of hormone secretion,GO:0046887~positive regulation of hormone secretion,[NAME]~digestive tract morphogenesis,GO:0048547~gut morphogenesis,GO:0048557~embryonic digestive tract morphogenesis,GO:0048562~[NAME] organ morphogenesis,GO:0048565~gut development,GO:0048567~ectodermal gut morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048619~[NAME] morphogenesis,GO:0048625~myoblast cell fate commitment,GO:0048806~genitalia development,[NAME]~stem cell differentiation,GO:0048864~stem cell development,GO:0048878~chemical homeostasis,GO:0050796~regulation of insulin secretion,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051176~positive regulation of sulfur metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0055123~digestive system development,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0060341~regulation of cellular localization,GO:0060548~negative regulation of cell death, | GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,[NAME]~[NAME],[NAME]~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~[NAME],GO:0044445~cytosolic part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070369~beta-catenin-TCF7L2 complex, | GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0016566~specific transcriptional repressor activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,[NAME]~protein kinase binding,GO:0030528~transcription regulator activity, | hsa04310:Wnt signaling pathway,hsa04520:Adherens junction,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05221:Acute myeloid leukemia,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), | A genome-wide association study identifies novel risk loci for type 2 diabetes,A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants,A variant in CDKAL1 influences insulin response and risk of type 2 diabetes,Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome wide association data,Diabetes mellitus, type 2, susceptibility to,Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels,Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls,Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes,Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes,Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium,
TLN2 | talin 2 | Homo sapiens | [NAME]~cytoskeleton organization,GO:0007016~cytoskeletal anchoring at plasma membrane,GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0008104~protein localization,GO:0022610~biological adhesion,GO:0032507~maintenance of protein location in cell,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0045185~maintenance of protein location,GO:0045216~cell-cell junction organization,GO:0051235~maintenance of location,GO:0051651~maintenance of location in cell, | GO:0001726~ruffle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,[NAME]cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0009898~internal side of plasma membrane,GO:0015629~[NAME],GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0070161~anchoring junction, | [NAME],GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0008092~cytoskeletal protein binding, | hsa04510:Focal adhesion,
[NAME] | thioredoxin-related transmembrane protein 3 | Homo sapiens | GO:0019725~cellular homeostasis,GO:0042592~homeostatic process,GO:0045454~cell redox homeostasis, | GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane, | GO:0003756~protein disulfide isomerase activity,GO:0016860~intramolecular oxidoreductase activity,GO:0016862~intramolecular oxidoreductase activity, interconverting keto- and enol-groups,GO:0016864~intramolecular oxidoreductase activity, transposing S-S bonds,
TTC14 | tetratricopeptide repeat domain 14 | Homo sapiens |  |  | GO:0003723~[NAME] binding,
TYRP1 | tyrosinase-related protein 1 | Homo sapiens | GO:0006582~melanin metabolic process,GO:0006631~fatty acid metabolic process,GO:0016050~vesicle organization,GO:0019748~secondary metabolic process,GO:0030318~melanocyte differentiation,GO:0032438~melanosome organization,GO:0033059~cellular pigmentation,GO:0042438~melanin biosynthetic process,GO:0042440~pigment metabolic process,[NAME]~butanoic acid metabolic process,GO:0043438~acetoacetic acid metabolic process,GO:0043473~pigmentation,GO:0046148~pigment biosynthetic process,GO:0046459~short-chain fatty acid metabolic process,GO:0048066~pigmentation during development,GO:0048753~pigment granule organization,GO:0050931~pigment cell differentiation,GO:0055114~oxidation reduction, | GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0031090~[NAME],GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0033162~melanosome membrane,GO:0042470~melanosome,GO:0044433~cytoplasmic vesicle part,GO:0045009~chitosome,GO:0048770~pigment granule, | GO:0005507~copper ion binding,GO:0016716~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity, | hsa00350:Tyrosine metabolism,hsa04916:Melanogenesis, | Albinism, brown,Albinism, rufous,Two newly identified genetic determinants of pigmentation in Europeans,
[NAME] | xylosyltransferase I | Homo sapiens | GO:0000271~polysaccharide biosynthetic process,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,[NAME]aminoglycan biosynthetic process,GO:0006024~glycosaminoglycan biosynthetic process,GO:0009266~response to temperature stimulus,GO:0009408~response to heat,GO:0009628~response to abiotic stimulus,GO:0016051~carbohydrate biosynthetic process,GO:0030203~glycosaminoglycan metabolic process,GO:0033554~cellular response to stress,GO:0034605~cellular response to heat, | GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane, | GO:0008375~acetylglucosaminyltransferase activity,GO:0016763~transferase activity, transferring pentosyl groups,GO:0030158~protein xylosyltransferase activity,GO:0035252~UDP-xylosyltransferase activity,GO:0042285~xylosyltransferase activity, | hsa00532:Chondroitin sulfate biosynthesis,hsa00534:Heparan sulfate biosynthesis, | Pseudoxanthoma elasticum, modifier of severity of,
ZNF586 | zinc finger protein 586 | Homo sapiens | GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process, |  | GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,